SCHEMBL4775889

SCHEMBL4775889

NC(C=O)C(c1ccccc1Cl)N1CCN(C(=O)c2cc(F)ccc2C(F)(F)F)CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SCN5A Q14524 3/20 0.42
SCN9A Q15858 3/20 0.42
EPHX2 P34913 1/20 0.40
SLC9A1 P19634 1/20 0.40
P2RX7 Q99572 4/20 0.39
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
RAB9A P51151 1/20 0.38
MGLL Q99685 1/20 0.38
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
SCD O00767 1/20 0.38
NPY2R P49146 1/20 0.37
HSD11B1 P28845 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4772658 0.92 CACNA2D1 (0.39) SCN5ASCN9AEPHX2P2RX7PSEN1
SCHEMBL4778523 0.85 SCD (0.40) P2RX7MGLLSCD
SCHEMBL4774662 0.82 CACNA1B (0.41) SCN5ASCN9AHDAC8HCRTR1HCRTR2
SCHEMBL4753765 0.81 HCRTR1 (0.44) SCN5ASCN9ASLC9A1P2RX7PSEN1
SCHEMBL4837579 0.80 SCD (0.38) SCN5ASCN9AEPHX2P2RX7HDAC8
Hydrochloric Acid SCHEMBL3466376 0.80 HCRTR1 (0.43) SCN5ASCN9ASLC9A1P2RX7PSEN1
SCHEMBL4780056 0.76 SCD (0.38) MGLLSCD
SCHEMBL4773443 0.76 HDAC8 (0.42) SCN5ASCN9AP2RX7PSEN1PSEN2
SCHEMBL4778400 0.75 HDAC8 (0.56) SCN5ASCN9AEPHX2P2RX7HDAC8
SCHEMBL4779187 0.74 MAPT (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1996550-A2 CARBOXYAMINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF HDAC DEPENDENT DISEASES Novartis AG (CH) 2008-12-03 EP claimed
WO-2007038459-A2 CARBOXYAMINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF HDAC DEPENDENT DISEASES NOVARTIS AG (CH) 2007-04-05 WO claimed